SAN FRANCISCO, Jan. 15, 2016 (GLOBE NEWSWIRE) -- Hagens Berman Sobol Shapiro LLP, a national investor-rights law firm, is investigating the recent plunge in share price in Natural Health Trends Corporation (NASDAQ:NHTC). Hagens Berman also alerts investors of the March 14, 2016 lead plaintiff deadline in the securities fraud class action lawsuit filed against the Company in connection with the reported investigation of the Company’s business practices by the Beijing Chaoyang District SAIC and the Chinese Public Security Bureau.
If you suffered losses because of your purchases of Natural Health Trends securities between March 6, 2015 and January 12, 2016, contact Hagens Berman Partner Reed Kathrein, who is leading the firm’s investigation by calling 510-725-3000, emailing [email protected] or visiting https://www.hbsslaw.com/cases/NHTC. The lawsuit was filed in the U.S. District Court for the Central District of California and investors have until March 14, 2016 to move the court to participate as a lead plaintiff.
Natural Health Trends operates as an international direct-selling and e-commerce company, and controls wholly-owned subsidiaries that have an active presence in North America, China, South Korea, Japan, and Europe. In China, the Company sells directly to consumers through its e-commerce platform.
On January 7, 2016, Seeking Alpha reported that the Company is under investigation by Chinese authorities. On this news, shares of Natural Health Trends fell $3.11 per share or over 10% from its previous closing price to close at $25.92 per share on January 7, 2016.
Then, on January 11 and 12, 2016 analyst firm GeoInvesting LLC issued two reports about the Company that corroborated earlier reports about the investigation, even though the Natural Health Trends denied knowledge of any such investigation. On these two days, the stock dropped again, dropping $2.65 per share, over 11%, on January 11, 2016 and an additional $1.51 per share, or over 7%, to close at $19.18 per share on January 12, 2016.
“While the stock’s recent drop relates only to the Chinese investigation, we continue to investigate the sudden slip starting around late December,” said Hagens Berman partner Reed Kathrein. “Often such a decline, on no discernable publicly reported news, means insiders or others are bailing out on anticipated news not shared with the public.”
If you are an investor who held Natural Health Trends securities between March 6, 2015 and January 12, 2016 and would like to learn more about this lawsuit, your ability to participate as a lead plaintiff, or our investigation, please contact us for your no-cost evaluation.
Whistleblowers: Persons with non-public information regarding Natural Health Trends in the United States or China should consider their options to help in the investigation or take advantage of the SEC Whistleblower program. Under the new SEC Whistleblower program, whistleblowers who provide original information may receive rewards totaling up to 30 percent of any successful recovery made by the SEC. For more information, call Reed Kathrein at (510) 725-3000 or email [email protected].
About Hagens Berman
Hagens Berman is headquartered in Seattle, Washington with offices in 10 cities. The Firm represents investors, whistleblowers, workers and consumers in complex litigation. More about the Firm and its successes can be found at www.hbsslaw.com. Read the Firm’s Securities Newsletter, and visit the blog. For the latest news visit our newsroom or follow us on Twitter at @classactionlaw.
Contact: Reed Kathrein, 510-725-3000


Taiwan Says Moving 40% of Semiconductor Production to the U.S. Is Impossible
Indian Refiners Scale Back Russian Oil Imports as U.S.-India Trade Deal Advances
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
SpaceX Prioritizes Moon Mission Before Mars as Starship Development Accelerates
Amazon Stock Rebounds After Earnings as $200B Capex Plan Sparks AI Spending Debate
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns
Innovent Biologics Shares Rally on New Eli Lilly Oncology and Immunology Deal
DBS Expects Slight Dip in 2026 Net Profit After Q4 Earnings Miss on Lower Interest Margins
SpaceX Pivots Toward Moon City as Musk Reframes Long-Term Space Vision
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Kroger Set to Name Former Walmart Executive Greg Foran as Next CEO
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia CEO Jensen Huang Says AI Investment Boom Is Just Beginning as NVDA Shares Surge 



